Markets:

Overview

News

Currencies

International

Treasuries

Harmony Biosciences Holdings, Inc. - Common Stock (NQ:HRMY)

31.50 +1.97 (+6.67%)

Streaming Delayed Price Updated: 3:01 PM EDT, Apr 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Harmony Biosciences Holdings, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Updates: HRMY, MELI, SWAV ↗

February 28, 2024

Another day, another slew of quarterly update reports for our followed stocks.

Via Talk Markets

Harmony Biosciences (HRMY) Q4 2023 Earnings Call Transcript ↗

February 22, 2024

HRMY earnings call for the period ending December 31, 2023.

Via The Motley Fool

Topics Earnings

Analyst Ratings For Harmony Biosciences ↗

February 22, 2024

Via Benzinga

Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates

February 22, 2024

From Harmony Biosciences

Via GlobeNewswire

The 3 Most Undervalued Small-Cap Stocks to Buy in February 2024 ↗

February 12, 2024

Small-cap stocks are the first ones to rally on a new business cycle, such as the business cycle starting recently.

Via InvestorPlace

NASDAQ:HRMY stands out as a growth opportunity that won't break the bank. ↗

January 10, 2024

Looking for growth without the hefty price tag? Consider NASDAQ:HRMY.

Via Chartmill

A Glimpse Into The Expert Outlook On Harmony Biosciences Through 6 Analysts ↗

January 02, 2024

Via Benzinga

Harmony Biosciences's Earnings Outlook ↗

October 30, 2023

Via Benzinga

Analyst Ratings for Harmony Biosciences ↗

October 16, 2023

Via Benzinga

The 3 Most Undervalued Russell 2000 Stocks to Buy in February 2024 ↗

February 07, 2024

Although the high-flying entities still capture Wall Street’s attention, astute investors should look to undervalued Russell 2000 stocks.

Via InvestorPlace

NASDAQ:HRMY: good value for what you're paying. ↗

January 25, 2024

In a market where value is scarce, HARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY) offers a refreshing opportunity with its solid fundamentals.

Via Chartmill

Investors should take notice of NASDAQ:HRMY—it offers a great deal for the fundamentals it presents. ↗

January 03, 2024

Don't overlook HARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY)—it's a hidden gem with strong fundamentals and an attractive price tag.

Via Chartmill

Why Harmony Biosciences Stock Got Slammed Today ↗

January 02, 2024

The commercial-stage company was dinged by a bearish new take from a researcher.

Via The Motley Fool

2023 Year In Review ↗

January 02, 2024

The S&P 500 had a strong year in 2023, returning about 24% to investors from the beginning of the year to the end. Some of that was a bounce back from a poor 2022 when it was down over 11%.

Via Talk Markets

Topics Stocks

NASDAQ:HRMY is showing good growth, while it is not too expensive. ↗

December 18, 2023

HARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY) stands out as a growth opportunity that won't break the bank.

Via Chartmill

7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar ↗

December 17, 2023

While the broader healthcare sector offers myriad opportunities, these undervalued biotech picks could offer robust upside.

Via InvestorPlace

NASDAQ:HRMY, an undervalued stock with good fundamentals. ↗

December 13, 2023

When you look at HARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY), it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.

Via Chartmill

Russell 2000 Front-Runners: 3 Stocks to Keep an Eye On ↗

December 07, 2023

Although Russell 2000 stocks may operate in the lightweight category, these entities could potentially provide a knockout punch.

Via InvestorPlace

Looking for growth without the hefty price tag? Consider NASDAQ:HRMY. ↗

November 27, 2023

Investors seeking growth at a reasonable cost should explore HARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY).

Via Chartmill

NASDAQ:HRMY is probably undervalued for the fundamentals it is displaying. ↗

November 22, 2023

HARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.

Via Chartmill

While growth is established for NASDAQ:HRMY, the stock's valuation remains reasonable. ↗

November 03, 2023

Investors should take note ofHARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY), a growth stock that remains attractively priced.

Via Chartmill

Quick Look At Reports From ServiceNow, Chipotle, And Harmony ↗

November 02, 2023

ServiceNow is a steady, reliable SaaS firm that continues to prove its value and growth potential to investors.

Via Talk Markets

NASDAQ:HRMY is an undervalued gem with solid fundamentals. ↗

November 01, 2023

For those who appreciate value investing, HARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY) is a compelling option with its solid fundamentals.

Via Chartmill

Harmony Biosciences (HRMY) Q3 2023 Earnings Call Transcript ↗

October 31, 2023

HRMY earnings call for the period ending September 30, 2023.

Via The Motley Fool

Topics Earnings

Arista Networks, JinkoSolar, Repligen, Shutterstock And Other Big Stocks Moving Higher On Tuesday ↗

October 31, 2023

U.S. stocks traded lower, with the Dow Jones falling more than 50 points on Tuesday. Here are some major stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

October 31, 2023

Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for...

Via Benzinga

Topics Intellectual Property

Harmony Biosciences Reports Strong Third Quarter 2023 Financial Results

October 31, 2023

From Harmony Biosciences

Via GlobeNewswire

Why Harmony Biosciences Stock Is Trading Higher Today ↗

October 16, 2023

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) shares are trading higher on Monday as the stock rebounds after falling Friday on Phase 3 INTU

Via Benzinga

Nasdaq Down Over 1%; Wells Fargo Beats Expectations ↗

October 13, 2023

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 1% on Friday. The Dow traded down 0.02% to 33,622.97 while the NASDAQ fell 1.27% to 13,401.56. The S&P...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 13, 2023

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.